Fibrosis and heart failure
- 4 November 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Heart Failure Reviews
- Vol. 19 (2), 173-185
- https://doi.org/10.1007/s10741-012-9365-4
Abstract
No abstract availableKeywords
This publication has 145 references indexed in Scilit:
- Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart FailureJama-Journal Of The American Medical Association, 2012
- Role of Endothelial-Mesenchymal Transition (EndoMT) in the Pathogenesis of Fibrotic DisordersThe American Journal of Pathology, 2011
- A randomized, controlled study of autologous therapy with bone marrow–derived aldehyde dehydrogenase bright cells in patients with critical limb ischemiaCatheterization and Cardiovascular Interventions, 2011
- Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current statusBritish Journal of Pharmacology, 2010
- Cellular and molecular pathways to myocardial necrosis and replacement fibrosisHeart Failure Reviews, 2010
- Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunctionAmerican Heart Journal, 2009
- Myocardial repair/remodelling following infarction: roles of local factorsCardiovascular Research, 2008
- TGFβ, cardiac fibroblasts, and the fibrotic responseCardiovascular Research, 2007
- The role of TGF-β signaling in myocardial infarction and cardiac remodelingCardiovascular Research, 2007
- Advanced Glycation Endproduct Crosslinking in the Cardiovascular SystemDrugs, 2004